Your Client Rank:
Loading...
99
Updated 05-Apr-2020
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Neurocrine | 23.9% | -0.5% | -11.6% | -17.8% | 41.8% | -0.5% | 96.2% | 88.3% |
| Vertex | 16.0% | 0.4% | -7.2% | -12.2% | 13.3% | 7.0% | 24.3% | 23.2% |
| Bristol | 12.9% | 1.4% | -4.7% | -0.7% | 6.1% | 2.8% | 16.8% | 10.9% |
| Exelixis | 12.2% | -0.1% | -5.1% | -6.0% | 7.8% | 2.2% | 18.7% | 17.4% |
| Astra | 9.9% | 0.3% | -5.2% | -4.5% | 11.7% | -0.1% | 19.1% | 18.9% |
| Mylan | 9.6% | 1.9% | 0.1% | -1.1% | 4.9% | -2.5% | 17.3% | -2.7% |
| AbbVie | 9.5% | -0.4% | 0.3% | -3.0% | -0.2% | 10.5% | 7.9% | 4.9% |
| Alexion | 7.0% | -0.1% | -2.6% | 5.1% | -1.1% | 4.4% | 5.7% | 6.2% |
| Daiichi | 7.0% | 1.3% | -0.7% | -1.8% | 8.4% | 7.7% | 12.8% | 13.3% |
| Eisai | 6.9% | -0.1% | -0.4% | -4.1% | 4.8% | 24.7% | 6.6% | 6.6% |
| Novo | 6.6% | -0.2% | -1.2% | 1.7% | 0.0% | 1.1% | 7.8% | 9.9% |
| Lilly | 6.2% | 0.4% | -3.4% | -3.3% | 5.5% | 4.8% | 10.8% | 11.9% |
| Merck KG | 5.8% | -0.1% | -1.9% | -1.9% | 8.6% | 0.0% | 10.1% | 9.9% |
| Regeneron | 5.7% | -0.2% | -0.7% | -5.3% | 4.1% | 1.6% | 7.1% | 6.5% |
| Chugai | 4.9% | 2.2% | -1.3% | 0.8% | 3.4% | -0.2% | 8.8% | 8.7% |
| Merck | 4.5% | 0.6% | -3.1% | -1.3% | 3.7% | 1.5% | 8.0% | 9.5% |
| Amgen | 4.3% | -0.1% | -1.1% | -0.6% | 0.2% | -0.7% | 4.6% | 7.0% |
| JnJ | 4.2% | 0.2% | -1.5% | -1.0% | 2.5% | 0.5% | 5.5% | 6.3% |
| Lundbeck | 4.1% | 0.4% | -0.6% | 0.9% | 7.1% | 0.3% | 6.2% | 7.3% |
| Novartis | 3.9% | 0.4% | -1.1% | -0.6% | 2.6% | 0.2% | 6.8% | 7.4% |
| Roche | 3.7% | 0.4% | -1.0% | -0.6% | 1.5% | 2.2% | 5.6% | 5.7% |
| Glaxo | 3.6% | 0.3% | -1.6% | 2.7% | 1.3% | 3.5% | 3.1% | 2.9% |
| Sanofi | 3.4% | 0.4% | -3.1% | -2.3% | 5.0% | -0.1% | 6.2% | 6.6% |
| Otsuka | 2.6% | 0.6% | -0.5% | 0.5% | 3.8% | 0.3% | 7.1% | 7.2% |
| UCB | 2.0% | 0.4% | 0.5% | -0.1% | 2.4% | 0.2% | 7.3% | 5.2% |
| Bayer | 1.8% | 0.5% | -2.9% | -0.4% | 15.9% | 7.6% | 7.5% | 7.7% |
| ONO | 1.6% | 0.1% | -1.4% | -1.8% | 2.9% | 0.1% | 4.8% | 5.1% |
| Takeda | 1.0% | 2.0% | -3.3% | -2.1% | 90.7% | | | |
| Astellas | 0.9% | 0.4% | | 0.0% | | | | |
| Gilead | 0.7% | 0.6% | 1.9% | 2.6% | -0.4% | 0.2% | 0.7% | 1.7% |
| Biogen | 0.6% | -0.2% | 4.4% | 0.0% | -1.7% | 3.3% | -1.4% | 1.5% |
| Shionogi | 0.6% | -0.1% | -1.2% | 4.4% | -1.0% | 0.3% | -0.4% | 1.8% |
| Pfizer | 0.5% | 0.4% | -3.2% | 1.4% | 1.9% | 0.1% | 3.5% | 4.5% |
| Teva | 0.4% | 1.0% | -0.7% | -0.8% | 2.4% | -0.3% | 4.7% | 4.4% |
| US Biotechs | 18.1% | -0.3% | -8.2% | -12.2% | 17.1% | 1.0% | 39.6% | 53.6% |
| EU Major | 4.2% | 0.5% | -2.2% | -0.6% | 4.2% | 1.8% | 7.3% | 7.8% |
| Other EU | 4.9% | -0.1% | -1.2% | -1.5% | 6.6% | 0.9% | 9.0% | 7.7% |
| US Major | 5.5% | 0.4% | -2.7% | -0.8% | 2.8% | 2.1% | 7.7% | 7.9% |
| US Big Biotech | 3.8% | 0.1% | 0.0% | -1.0% | 0.4% | 1.2% | 4.1% | 5.9% |
| Other US | 4.6% | 1.6% | -0.4% | -1.5% | 4.2% | -1.5% | 11.3% | 0.0% |
| Japanese | 2.8% | 1.1% | -1.4% | -0.9% | 15.1% | -1.3% | 22.4% | 11.1% |